Objective: To establish the association of androgenetic alopecia (AGA) and the severity of coronavirus disease 2019 .Design: Observational study.Methodology: A total of 300 hospitalized patients of COVID-19 were included.Scoring of AGA was done, and severity of COVID-19 was measured as better and worse hospital outcomes. Correlation between severity of AGA and severity of COVID-19 was noted.Results: Out of 300 patients, 220 (73.33%) were male and 80 (26.67%) were female.

Background COVID‐19 has been linked to a variety of dermatological conditions. Objective To determine the presence of various cutaneous manifestations in patients with COVID‐19, also to define their features in relation to the systemic symptoms. Methods This research enrolled a total of 1206 lab‐confirmed COVID‐19 individuals at a tertiary care hospital in Karachi, Pakistan. Expert dermatologists assessed patients for COVID‐related skin conditions. COVID‐19 severity was categorized as asymptomatic/mild, moderate, or severe. Results Of the 102 (85.7%) patients with only one cutaneous sign, 26.5% developed maculo‐papular/morbiliform/erythematous rash; 14.7% urticaria; 9.85% vesicular/pustular exanthem; 14.7% vascular pattern; 12.7% infections, 7.8% miscellaneous and 9.8% late cutaneous findings A longer‐lasting vascular pattern was related with an older age and a fatal COVID‐19 outcomes (P: 0.000) compared to mild/moderate disease. Most of the retiform purpura presented exclusively with thromboembolic episodes. The moderate severity was correlated with maculopapular/morbiliform/exanthematous phenotype (P: 0.009), whereas urticaria was attributed to asymptomatic/mild disease (0.001) compared to moderate/severe infection. Limitations Single‐Centre and observational study. Conclusion Vascular lesions were correlated with disastrous COVID‐19 outcomes, whereas retiform purpura was linked to adverse outcomes. The maculopapular/morbiliform/erythematous rash was associated with moderate severity, whilst the urticarial rash was linked to milder course compared to moderate/severe severity infection.